Nature: "An AI boost for clinical trials"
We're pleased to see Antidote mentioned in Nature International Journal of Science for our work in natural language processing (NLF) to help patients connect with clinical trials.
The Nature article covers how companies are using artificial intelligence to make it easier for patients to connect with research opportunities:
"Machine-learning algorithms rely on being fed training data from which they can learn — and to reach their potential, they need plenty. But labelling important features in these data, as is required to train NLP algorithms, is time consuming. The problem in academia, Weng says, is that both data and people power are limited.
Industry might be better placed to overcome those obstacles, and the past few years have seen a burst of activity. For example, digital-health company Antidote in New York City has developed a tool that helps people to search for trials."
Read more in Nature.